Présentations scientifiques

17
Mai 2023
18:31 E.S.T.

AMELI 01: A Phase I Trial of UCART123v1.2, an Anti CD123 Allogeneic CAR T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia – ASGCT 2023 – Présentation orale

Télécharger le PDF
16
Avr 2023
12:00 E.S.T.

Deciphering the benefits of variable delivery routes and molecular armoring to enhance efficacy of MUC1-CAR T-cells in targeting triple-negative breast cancer – AACR 2023 – Présentation poster

Télécharger le PDF
13
Déc 2022
09:22 E.S.T.

AMELI-01:Preliminary Results from A Phase I Trial of UCART123v1.2, an Anti-CD123 Allogeneic CAR-T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia – ASH 2022 – Présentation orale

Télécharger le PDF
12
Déc 2022
10:52 E.S.T.

Preclinical Activity of Allogeneic CS1-Specific CAR T-Cells (UCARTCS1) in Multiple Myeloma – ASH 2022 – Présentation poster

Télécharger le PDF
11
Avr 2022
15:16 E.S.T.

UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies – AACR 2022 – Abstract

Télécharger le PDF
11
Avr 2022
15:13 E.S.T.

UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies – AACR 2022 – Poster Presentation

Télécharger le PDF
27
Oct 2021
13:20 E.S.T.

Preclinical development of a TALEN-based genome editing in T cells for the treatment of Hyper-IgE-Syndrome – ESGCT 2021- Oral Presentation

Télécharger le PDF

Scientific publications

Discover Cellectis' scientific publications

Learn more